Chair Audit & Risk Committee
Mr Burrill has held a number of senior pharmaceutical industry executive roles, including Corporate Vice President, Global Pharma Research and Development for Hospira Inc., one of the top 10 generic companies globally. In this role he was responsible for overall pipeline portfolio management, and research and development of generic and speciality pharmaceuticals. Prior to this he held other senior international roles within Hospira and the original Mayne Pharma. He currently provides consulting services in the area of pharmaceutical strategic management, product development, regulatory affairs and intellectual property. Additionally he previously served as Managing Director of CCH Pharma Pty Ltd. Since 2007 he has been Non-Executive Director and Deputy Chair (July 2015) of Nova Aerospace Pty Ltd.